文献速递腹部介入CT

动态CT灌注成像:从诊断到治疗随访评估肝细胞癌的补充诊断工具

Dynamic Computed Tomography Perfusion Imaging: Complementary Diagnostic Tool in Hepatocellular Carcinoma Assessment From Diagnosis to Treatment Follow-up.
PubMed 文献 · Acad Radiol · 2019-03-07

本文从技术角度分析灌注CT(pCT),描述组织灌注量化的主要数学分析模型、常用灌注参数及标准pCT检查所需技术参数。同时系统综述文献,评估pCT作为新兴影像生物标志物在HCC诊断及RFA、TACE、索拉非尼治疗反应评估中的作用,并探讨其在HCC管理中的挑战。

要点

  • pCT可提供形态学信息之外的定量功能数据,作为HCC评估的补充诊断工具。
  • 本文系统综述pCT在HCC诊断及RFA、TACE、索拉非尼治疗反应评估中的作用。
  • 本文描述了pCT的主要数学分析模型、常用灌注参数及标准检查的技术参数。

核心结论

  • pCT作为新兴影像生物标志物,在HCC诊断及RFA、TACE、索拉非尼治疗反应评估中具有潜在作用,但其在HCC管理中仍面临挑战。

研究设计与样本

  • 本文为综述,从技术角度分析pCT的数学分析模型、灌注参数及标准检查技术参数,并系统综述文献评估pCT在HCC诊断和治疗反应评估中的作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Early diagnosis of HCC is of paramount importance in order to enable the application of curative treatments. Among these, radiofrequency ablation (RFA) is actually considered the most effective ablative therapy for early stage hepatocellular carcinoma (HCC) not suitable for surgery. On the other hand, transarterial chemoembolization (TACE) represents the standard of care for intermediate stage HCC and compensated liver function. Finally, sorafenib, an oral antiangiogenic targeted drug, is the only approved systemic therapy for advanced HCC with vascular invasion, extrahepatic spread, and well-preserved liver function. Beside traditional radiological techniques, new functional imaging tools have been introduced in order to provide not only morphological information but also quantitative functional data. In this review, we analyze perfusion-CT (pCT) from a technical point of view, describing the main different mathematical analytical models for the quantification of tissue perfusion from acquired CT raw data, the most commonly acquired perfusion parameters, and the technical parameters required to perform a standard pCT examination. Moreover, a systematic review of the literature was performed to assess the role of pCT as an emerging imaging biomarker for HCC diagnosis, response evaluation to RFA, TACE, and sorafenib, and we examine its challenges in HCC management.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Ippolito D, Pecorelli A, Querques G, et al. Dynamic Computed Tomography Perfusion Imaging: Complementary Diagnostic Tool in Hepatocellular Carcinoma Assessment From Diagnosis to Treatment Follow-up. Acad Radiol. 2019. PMID: 30852079. doi:10.1016/j.acra.2019.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。